Facing the 2020 Pandemic: What does Cyberbiosecurity want us to know to safeguard the future?

As the entire world is under the grip of the Coronavirus diseases 2019 (COVID-19), and as many are eagerly trying to explain the origins of the virus and cause of the pandemic, it is imperative to place more attention on related potential biosafety risks. Biology and biotechnology have changed dramatically during the last ten years or so. Their reliance on digitization, automation, and their cyber-overlaps have created new vulnerabilities for unintended consequences and potentials for intended exploitation that are largely under-appreciated. Herein, I summarize and elaborate on these new cyberbiosecurity challenges, (1) in terms of comprehending the evolving threat landscape and determining new risk potentials, (2) in developing adequate safeguarding measures, their validation and implementation, and (3) specific critical dangers and consequences, many of them unique to the life-sciences. Drawing upon expertise shared by others as well as my previous work, this article aims to summarize and critically interpret the current situation of our bioeconomy. Herein, the goal is not to attribute causative aspects of past biosafety or biosecurity events, but to highlight the fact that the bioeconomy harbors unique features that have to be more critically assessed for their potential to unintentionally cause harm to human health or environment, or to be re-tasked with an intention to cause harm. I conclude with recommendations that will need to be taken into consideration to help ensure converging and emerging biorisk challenges, in order to minimize vulnerabilities to the life-science enterprise, public health, and national security.

• Tipo de recurso: Article of investigation
• Fecha de publicación: 2020
• Institución: Universidad de Bogotá Jorge Tadeo Lozano
• Repositorio: Expeditio: repositorio UTadeo
• Idioma: eng
• OAI Identifier: oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14263
• Acceso en línea: https://doi.org/10.1016/j.bsheal.2020.09.007; http://hdl.handle.net/20.500.12010/14263
• Palabra clave: Laboratory safety; Cyberbiosecurity; Risk assessment; Protective measures; Convergence; Biolabs of the future; Síndrome respiratorio agudo grave; COVID-19; SARS-CoV-2; Coronavirus
• License: Abierto (Texto Completo)